JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...
The collaborative Microarray Innovations in Leukemia (MILE) study program was designed to assess the clinical accuracy of gene expression profiles (compared with current routine diagnostic work-up) of ...
Sensitivity: 97.4% Specificity: 100% Positive Predictive Value (PPV): 100% Negative Predictive Value (NPV): 99.4% For 8 copy number variants (CNVs) detected by CMA, OGM defined their location and ...
The mutation status of the epidermal growth factor receptor (EGFR) as a selection criterion for therapy with EGFR tyrosine kinase inhibitors (TKI’s) in non-small cell lung cancer (NSCLC) No ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
Thanks to new advances, breast cancer can be a beatable disease, but there is still a lot we do not know about breast cancer. New technology is helping doctors learn more. Researchers at UNC are using ...